Urgent

AV nodal re-entrant tachycardia (AVNRT)

Regular narrow-complex SVT · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Abrupt-onset regular narrow-complex tachycardia (typically 150-250/min) from re-entry within the AV node; the commonest paroxysmal SVT.

Red flags

  • Haemodynamic instability
  • Ischaemic chest pain or ST changes
  • Syncope
  • Wide QRS raising pre-excitation

Assessment

Differential diagnosis

  • Atrial flutter with 2:1 block
  • Focal atrial tachycardia
  • Orthodromic AVRT
  • Sinus tachycardia
  • Junctional tachycardia

Investigations

  • 12-lead ECG (pseudo-R in V1, retrograde P waves)
  • Continuous rhythm monitoring
  • Electrolytes, magnesium and TFTs
  • Troponin if chest pain

Management

  • Confirm regular narrow QRS and assess haemodynamic status
  • Trial vagal manoeuvres (modified Valsalva) with monitoring
  • If persists give adenosine 6 mg rapid IV, then 12 mg if needed
  • If unstable perform synchronised DC cardioversion
  • If adenosine fails and stable use a rate-limiting CCB or beta-blocker
  • Refer for electrophysiology study and ablation

Drugs & doses

Adenosine (antiarrhythmic) - 6 mg rapid IV push, repeat 12 mg
Verapamil (CCB) - 2.5-5 mg slow IV if stable and definitely narrow QRS
Metoprolol (beta-blocker) - IV/oral rate control

Disposition

Discharge after reversion with EP referral; admit if unstable or structural heart disease.

Complications & pitfalls

  • Recurrence
  • Tachycardia-induced cardiomyopathy if incessant
  • Transient asystole or bronchospasm with adenosine

Exam pearls

  • Record a continuous strip across adenosine administration
  • Avoid adenosine in severe asthma
  • Modified Valsalva (leg lift) improves reversion rates

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.